A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Icu Medical Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 3,400 shares of ICUI stock, worth $569,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,400
Previous 700 385.71%
Holding current value
$569,806
Previous $83,000 645.78%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.88 - $182.17 $51.4 Million - $81.5 Million
447,512 Added 217.42%
653,341 $119 Million
Q2 2024

Aug 14, 2024

BUY
$94.53 - $120.55 $1.43 Million - $1.82 Million
15,088 Added 7.91%
205,829 $24.4 Million
Q1 2024

May 15, 2024

BUY
$86.88 - $112.48 $7.18 Million - $9.3 Million
82,693 Added 76.53%
190,741 $20.5 Million
Q4 2023

Feb 14, 2024

BUY
$81.08 - $119.29 $8.46 Million - $12.4 Million
104,345 Added 2817.85%
108,048 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$115.27 - $182.23 $404,021 - $638,716
3,505 Added 1770.2%
3,703 $440,000
Q2 2023

Aug 14, 2023

BUY
$161.03 - $209.15 $31,883 - $41,411
198 New
198 $35,000
Q2 2022

Aug 15, 2022

BUY
$161.4 - $229.7 $996,322 - $1.42 Million
6,173 Added 104.05%
12,106 $1.99 Million
Q1 2022

May 16, 2022

SELL
$203.51 - $247.46 $15.9 Million - $19.3 Million
-77,908 Reduced 92.92%
5,933 $1.32 Million
Q4 2021

Feb 14, 2022

BUY
$220.96 - $247.44 $2.99 Million - $3.35 Million
13,530 Added 19.24%
83,841 $19.9 Million
Q3 2021

Nov 15, 2021

SELL
$186.8 - $260.0 $26 Million - $36.2 Million
-139,178 Reduced 66.44%
70,311 $16.4 Million
Q2 2021

Aug 16, 2021

BUY
$190.83 - $215.73 $5.18 Million - $5.85 Million
27,125 Added 14.87%
209,489 $43.1 Million
Q1 2021

May 17, 2021

BUY
$197.58 - $222.54 $17.6 Million - $19.8 Million
89,115 Added 95.57%
182,364 $37.5 Million
Q4 2020

Feb 16, 2021

BUY
$177.6 - $214.65 $13.4 Million - $16.2 Million
75,506 Added 425.55%
93,249 $20 Million
Q3 2020

Nov 16, 2020

SELL
$177.7 - $200.24 $1.49 Million - $1.67 Million
-8,361 Reduced 32.03%
17,743 $3.24 Million
Q2 2020

Aug 14, 2020

SELL
$172.31 - $230.89 $80.3 Million - $108 Million
-466,204 Reduced 94.7%
26,104 $4.81 Million
Q1 2020

May 15, 2020

BUY
$160.04 - $216.15 $9.75 Million - $13.2 Million
60,938 Added 14.13%
492,308 $99.3 Million
Q4 2019

Feb 14, 2020

BUY
$151.88 - $189.51 $26.7 Million - $33.3 Million
175,629 Added 68.67%
431,370 $80.7 Million
Q3 2019

Nov 14, 2019

BUY
$154.21 - $257.38 $37.3 Million - $62.2 Million
241,707 Added 1722.3%
255,741 $40.8 Million
Q2 2019

Aug 14, 2019

BUY
$212.8 - $251.91 $1.91 Million - $2.26 Million
8,955 Added 176.31%
14,034 $3.54 Million
Q1 2019

May 15, 2019

SELL
$221.09 - $253.28 $4.59 Million - $5.26 Million
-20,757 Reduced 80.34%
5,079 $0
Q4 2018

Feb 14, 2019

SELL
$213.13 - $281.01 $7.37 Million - $9.72 Million
-34,589 Reduced 57.24%
25,836 $5.93 Million
Q3 2018

Nov 13, 2018

BUY
$265.5 - $307.63 $9.37 Million - $10.9 Million
35,308 Added 140.57%
60,425 $0
Q2 2018

Aug 10, 2018

BUY
$245.65 - $309.75 $5.83 Million - $7.36 Million
23,747 Added 1733.36%
25,117 $0
Q1 2018

May 11, 2018

SELL
$213.2 - $261.85 $10.3 Million - $12.6 Million
-48,224 Reduced 97.24%
1,370 $346,000
Q4 2017

Feb 09, 2018

SELL
$186.1 - $220.45 $8.93 Million - $10.6 Million
-47,985 Reduced 49.18%
49,594 $10.7 Million
Q3 2017

Nov 09, 2017

BUY
$164.9 - $187.15 $16.1 Million - $18.3 Million
97,579
97,579 $18.1 Million

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $4.01B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.